Filing Details
- Accession Number:
- 0001311241-13-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-03 18:52:30
- Reporting Period:
- 2012-12-31
- Filing Date:
- 2013-01-03
- Accepted Time:
- 2013-01-03 18:52:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1311241 | Intermolecular Inc | IMI | Semiconductors & Related Devices (3674) | 201616267 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1269893 | M Bruce Mcwilliams | C/O Intermolecular, Inc. 3011 North First Street San Jose CA 95134-2004 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2012-12-31 | 1,350 | $9.04 | 218,650 | No | 4 | S | Indirect | By Trust |
Common Stock, $0.001 Par Value | Disposition | 2013-01-02 | 9,200 | $9.00 | 209,450 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Footnotes
- The sale reported was effected pursuant to a 10b5-1 Stock Trading Plan entered into by the Reporting Person on July 31, 2012.
- The transaction was executed in multiple trades in prices ranging from $9.00 to $9.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- These shares are held by the Bruce and Astrid McWilliams 1997 Trust UAD 11/06/09.
- The transaction was executed in multiple trades in prices ranging from $9.00 to $9.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.